These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1456202)

  • 1. Approval for broader use of DDI.
    Am Fam Physician; 1992 Dec; 46(6):1841-2. PubMed ID: 1456202
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence strategies. FDA approves ddI generic version.
    AIDS Alert; 2006 Nov; 21(11):131. PubMed ID: 17111491
    [No Abstract]   [Full Text] [Related]  

  • 3. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of didanosine (ddI) in the adult: a nursing perspective.
    Vaccariello J; Funesti JC; Laverty MK; Vasquez M; Curran-Krikorian K
    J Assoc Nurses AIDS Care; 1993; 4(1):23-9. PubMed ID: 8481500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 6. ddI: FDA approves once-daily dosing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1999 Nov; (No 330):1. PubMed ID: 11367169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. Zidovudine approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19928325
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Generic zidovudine oral solution approved.
    AIDS Alert; 2008 Aug; 23(8):90. PubMed ID: 18724489
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric efficacy supplement for Videx EC.
    AIDS Patient Care STDS; 2008 Nov; 22(11):919. PubMed ID: 19043843
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of zidovudine in HIV infection.
    Am Fam Physician; 1991 May; 43(5):1852. PubMed ID: 2021110
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M
    AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic didanosine gets approved.
    AIDS Patient Care STDS; 2005 Mar; 19(3):201-2. PubMed ID: 15841566
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDI more effective than AZT.
    Minn Med; 1992 Jun; 75(6):54. PubMed ID: 1495461
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children.
    Engchanil C; Kosalaraksa P; Lumbiganon P; Lulitanond V; Pongjunyakul P; Thuennadee R; Tungsawad S; Suwan-apichon O
    J Med Assoc Thai; 2006 Aug; 89(8):1229-36. PubMed ID: 17048434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
    Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.